Clinical trials in Poughkeepsie, NY

10 recruiting studies have a site in or near Poughkeepsie, NY, New York.

Top conditions here

All conditions

Showing 10 of 10 studies

RecruitingPhase 2 / Phase 3NCT06712316

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer (ROSETTA Lung-02)

Sponsor: BioNTech SE

Poughkeepsie, NY · Stony Brook, NY · White Plains, NY · +50 more sites

RecruitingPhase 3NCT07181109

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

Sponsor: Alnylam Pharmaceuticals

New Windsor, NY · North Massapequa, NY · Poughkeepsie, NY · +270 more sites

RecruitingPhase 3NCT07037433

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Sponsor: Amgen

Binghamton, NY · Poughkeepsie, NY · Rochester, NY · +137 more sites

RecruitingPhase 3NCT07037459

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

Sponsor: Amgen

Albany, NY · New York, NY · Poughkeepsie, NY · +118 more sites

RecruitingPhase 3NCT05879926

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Sponsor: NRG Oncology

Bay Shore, NY · Bronxville, NY · Brooklyn, NY · +1223 more sites

RecruitingNot applicableNCT05677100

Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure

Sponsor: Procyrion

Brooklyn, NY · New York, NY · +46 more sites

RecruitingPhase not listedNCT00271180

Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products

Sponsor: Medtronic

Huntington, NY · Manhasset, NY · New York, NY · +110 more sites

RecruitingPhase 3NCT05812807

Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

Sponsor: Alliance for Clinical Trials in Oncology

Bay Shore, NY · Brooklyn, NY · +825 more sites

RecruitingNot applicableNCT03142152

The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR

Sponsor: Cardiac Dimensions, Inc.

Albany, NY · Buffalo, NY · New York, NY · +72 more sites

RecruitingPhase 3NCT05929768

Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer

Sponsor: SWOG Cancer Research Network

Bay Shore, NY · Brooklyn, NY · Glens Falls, NY · +952 more sites

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.